AffiliationDepartment of Surgery, Christie Hospital, Manchester, UK.
MetadataShow full item record
AbstractA high level of hypoxia in solid tumours is an adverse prognostic factor for the poor outcome of cancer patients following treatment. This review describes the status of research into finding a practical method for measuring hypoxia and treating hypoxic tumours. The application of such methodology would enable the selection of head and neck cancer treatment based on an individual's tumour oxygenation status. This individualization would include the selection not only of surgery or radiotherapy, but also of novel hypoxia-modification strategies.
CitationHypoxia in head and neck cancer. 2006, 79 (946):791-8 Br J Radiol
JournalThe British Journal of Radiology
- Hypoxic sensitizer and cytotoxin for head and neck cancer.
- Authors: Lee DJ, Moini M, Giuliano J, Westra WH
- Issue date: 1996 May
- Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
- Authors: Koukourakis MI, Giatromanolaki A, Sivridis E, Pastorek J, Karapantzos I, Gatter KC, Harris AL, Tumour and Angiogenesis Research Group.
- Issue date: 2004 May 1
- Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.
- Authors: Bussink J, Kaanders JH, van der Kogel AJ
- Issue date: 2003 Apr
- Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
- Authors: Vordermark D, Brown JM
- Issue date: 2003 Dec
- Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients.
- Authors: Le QT, Kovacs MS, Dorie MJ, Koong A, Terris DJ, Pinto HA, Goffinet DR, Nowels K, Bloch D, Brown JM
- Issue date: 2003 Jun 1